Skip to main content

Table 1 Clinical parameters of patients with DLBCL

From: P38 MAPK expression and activation predicts failure of response to CHOP in patients with Diffuse Large B-Cell Lymphoma

Clinical parameters

Frequency n (%)

Gender

 

 Male

45 (56)

 Female

35 (44)

Age

 

Media, range

55.15–85

Stage

 

 I-II

28 (35)

 III -IV

52 (65)

LDH

 

 Normal

42 (52)

 High

38 (48)

Performance Status

 

 0–1

60 (75)

 2–4

20 (25)

IPI

 

 0–2

57 (72)

 3–5

23 (28)

Bcl-2

 

 Positive

30 (37)

 Negative

50 (63)

NF-kB

 

 Positive

26 (32)

 Negative

54 (68)

Phenotype

 

 GCB

58 (72)

 ABC

22 (28)